RECENT NEWS

The UK Government is to award funding of £33.2 million to eight vaccine projects targeting deadly diseases, strengthening UK pandemic preparedness and helping protect people worldwide.

A ‘rising fog’ which may cloud the immune system’s ability to detect tumours could be the key to tackling lung cancer development years before diagnosis.

The National Institute for Health and Care Research (NIHR) and the National Health Innovation Centre Singapore (NHIC) are teaming up to fast-track healthcare innovations across the UK and Singapore that address unmet, shared clinical needs.

The UK Health Security Agency (UKHSA) has appointed Dr Gail Carson as its new Chief Medical Advisor, and confirmed the permanent appointment of Professor Robin May as its Chief Scientific Officer.

ALZpath and Quanterix have announced the expansion of their cooperation, which will broaden the use of ALZpath's proprietary pTau217 antibody technology across the Quanterix Simoa research portfolio.

Aiforia, a developer of AI-powered solutions for cancer diagnostics, has won the prestigious ‘Vuoden Digiteko 2026’ (Digital Innovation of the Year) public vote in the enterprise category.

Consultant Clinical Scientist Dr Fiona Riddoch has been appointed as Specialty Lead for Point-of-Care Testing across the Berkshire and Surrey Pathology Services (BSPS) network.

The UK Health Security Agency (UKHSA) has highlighted that influenza levels during September – while still low - were higher than in the previous four years, raising the prospect of an early ‘flu season.

Roche Diagnostics has provided two molecular testing instruments to the Democratic Republic of Congo’s Institut National de Santé Publique (INSP) to support Ebola testing capacity in the country.

AI Pathology firm Aiforia has announced a commercial agreement with PathAI - the developer of the AISight Dx Image Management System - for Aiforia's AI solutions to be made available to laboratories through the AISight Marketplace.

Lab Innovations, the UK’s largest annual trade show for laboratory professionals and their organisations, has released its show conference programme for 2026, featuring speakers from academic to media backgrounds.

Newly published research uncovers how bacteria fight infection by bacteriophages (phages), opening the door to better virus-based antibiotics.

The Royal College of Pathologists (RCPath) is once again delivering a busy programme for National Pathology Week and International Pathology Day, taking place during November.

The Government has confirmed it will accept all 44 recommendations made by the National Commission into the Regulation of AI in Healthcare. Alongside the response, the MHRA is opening the call for applications for the third phase of AI Airlock, its regulatory sandbox for AI-enabled medical devices.

People who recovered from COVID-19 infection or were vaccinated against SARS-CoV-2 are more likely to have immunity to other closely related bat coronaviruses that could have the potential to threaten future human health.

Pregnant women are currently being recruited to a world-first clinical trial testing a new group B streptococcal vaccine in UK hospitals, which could prevent infant deaths and stillbirths from a life-threatening bacterial infection.

Evident has completed the acquisition of CrestOptics SpA, a Rome-based developer and manufacturer of advanced optical imaging systems for spinning disk confocal and super-resolution microscopy.

New England Biolabs (NEB) UK and the Microbiology Society have announced a new partnership to widen access to microbiology for under-represented communities.

Thousands more people in Northern Ireland will be invited for potentially life-saving bowel cancer screening after Health Minister Robbie Butler announced a major expansion of the regional screening programme.

PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.